Table 4: Viral co-infections detected in the patients studied, according to the type of transplant.
|
Virus |
Patients overall n = 236 (100%) |
Type of recipient |
|||||
|
Liver |
Kidney |
Bone marrow |
|||||
|
pediatric n = 30 |
Adult n = 44 |
pediatric n = 13 |
Adult n = 96 |
pediatric n = 5 |
Adult n = 48 |
||
|
CMV/BK |
20 (8.5) |
5 (16.7) |
2 (4.5) |
3 (23.1) |
6 (6.3) |
1 (20.0) |
3 (6.3) |
|
CMV/HSV |
1 (0.4) |
0 (0.0) |
1 (2.3) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
|
CMV/HHV6 |
1 (0.4) |
1 (3.3) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
|
CMV/EBV |
3 (1.3) |
1 (3.3) |
1 (2.3) |
0 (0.0) |
1 (1.0) |
0 (0.0) |
0 (0.0) |
|
CMV/JC |
2 (0.8) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
1 (1.0) |
0 (0.0) |
1 (2.1) |
|
BK/JC |
2 (0.8) |
1 (3.3) |
1 (2.3) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
|
BK/HHV6 |
1 (0.4) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
1 (2.1) |
|
BK/HSV |
1 (0.4) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
1 (2.1) |
|
BK/EBV |
1 (0.4) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
1 (1.0) |
0 (0.0) |
0 (0.0) |
|
HSV/HHV6 |
1 (0.4) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
1 (2.1) |
|
CMV/EBV/BK |
2 (0.4) |
0 (0.0) |
1 (2.3) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
1 (2.1) |
|
total co-infections |
35 (14.8%) |
8 (26.7) |
6 (13.6) |
3 (23.1) |
9 (9.4) |
1 (20.0) |
8 (16.7) |